Okita, Yoshiko
Kano-Fujiwara, Rieko
Nakatsuka, Shin-Ichi
Honma, Keiichiro
Kinoshita, Manabu http://orcid.org/0000-0001-7923-6902
Article History
Received: 29 March 2021
Accepted: 15 April 2021
First Online: 26 April 2021
Declarations
:
: Approval for the clinical trial was obtained from Osaka Prefectural Hospital Organization Osaka International Cancer Institute Certified Review Board. The authors obtained the patient’s consent to participate in the study.
: The authors obtained informed consent from the patient to publish information on her disease and clinical course.
: The authors have no relevant financial or non-financial interests to disclose.